The 38 small molecule compounds were molecularly docked with seven hub genes, and the results showed that most drugs had good binding affinity with AURKA, CDK1 and EZH2 proteins, and had the potential to become inhibitors of the corresponding targets, thereby playing a role in the treatment of SCCE. Here, EZH2 is linked to cervical small cell carcinoma.